Statements and Comment Letters
March 29, 2023 – PAVC and other stakeholders send letter of support to sponsors of the Telehealth Benefit Expansion for Workers Act (H.R. 824) | Read the Full Letter
March 29, 2023 – PAVC submits comments on two Drug Enforcement Agency (DEA) proposed rules related to the prescription of controlled substances, including buprenorphine, without a requirement for an in-person visit | Read the Full Letter
January 30, 2023 – PAVC submits comments on the bipartisan CONNECT for Health Act | Read the Full Letter
January 26, 2023 – PAVC signs stakeholder letter to CMS on extending telehealth codes through CY 2024 | Read the Full Letter
Issue Briefs and Advocacy Materials
DEA proposes limited post-PHE telemedicine prescription of controlled substances | View the Special Report
Snapshot of expanded access to virtual care during the pandemic | View the Infographic
Repealing the in-person requirement for mental telehealth services | Read the Full Brief
Congress must act to ensure continued access to telehealth services for those with HSA-eligible HDHPs
Read background document | View the Infographic